Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsTOPICALStandard

ERYTHROMYCIN AND BENZOYL PEROXIDE

BENZOYL PEROXIDE; ERYTHROMYCIN

Standard Dose
5%;3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription

Key Takeaways

  • Primary indication: Marketing status: Prescription
  • Approval overview ERYTHROMYCIN AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 065385 (ANDA).
  • Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; ERYTHROMYCIN Form and strength GEL;TOPICAL - 5%;3% Sponsor RISING Submission history Latest submission status date: 2015-09-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN AND BENZOYL PEROXIDE is listed in Drugs@FDA under application 065385 (ANDA). Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; ERYTHROMYCIN Form and strength GEL;TOPICAL - 5%;3% Sponsor RISING Submission history Latest submission status date: 2015-09-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.